In vitro antileishmanial activities of three medicinal plants: argemonemexicana, murraya koenigii and cinnamomum tamala against miltefosine resistant promastigotes of leishmania donovani parasites
By: Sirin, Salma Sultana
.
Publisher: M P Innovare Academic Sciences Pvt Ltd 2021Edition: Vol.13(9).Description: 27-33p.Subject(s): PHARMACEUTICSOnline resources: Click here
In:
International journal of pharmacy and pharmaceutical scienceSummary: Objective: Leishmaniasis is one of the neglected tropical diseases in terms of drug development and discovery. Non-responsiveness and resistance to the drug in Leishmaniaspecies need to develop new antileishmanial potentials; herbal medicines could be the alternative one.Methods: In the present study, semi-purified fractions were prepared from the traditionally used three medicinal plants of India: Argemone mexicana (aerial shoot), Murraya koenigii (stem), and Cinnamomum tamala (bark) by using multiple solvent systems (non-polar to polar, beginning with petroleum ether followed by n-hexane, benzene, and chloroform) and an effort was given to assess the leishmanicidal activities against Leishmania donovani miltefosine resistant HePC-R (Ld/MIL-30) promastigotes in vitroand the IC50 concentrations were estimated.Results: The study revealed that the semi-purified fractions of A. mexicana, M. koenigii, and C.tamala have effective antileishmanial activities and the 50% inhibitory concentrations (IC50) are 50 μg/ml, 98 μg/ml, and 200 μg/ml, respectively. At these (IC50) concentrations, these plant semi-purified fractions were found to interfere in lipid and protein biosynthesis, alter cell morphology, DNA content, mitochondrial membrane potential, generating ROS, and apoptosis in promastigotes. The semi-purified fractions were also found noticeably non-toxic towards host splenocytes.Conclusion: These results could suggest that A. mexicana, M. koenigii, and C.tamala could carry potential novel compounds for the development of new drugs against Leishmaniasis.
| Item type | Current location | Call number | Status | Date due | Barcode | Item holds |
|---|---|---|---|---|---|---|
Articles Abstract Database
|
School of Pharmacy Archieval Section | Not for loan | 2022-0427 |
Objective: Leishmaniasis is one of the neglected tropical diseases in terms of drug development and discovery. Non-responsiveness and resistance to the drug in Leishmaniaspecies need to develop new antileishmanial potentials; herbal medicines could be the alternative one.Methods: In the present study, semi-purified fractions were prepared from the traditionally used three medicinal plants of India: Argemone mexicana (aerial shoot), Murraya koenigii (stem), and Cinnamomum tamala (bark) by using multiple solvent systems (non-polar to polar, beginning with petroleum ether followed by n-hexane, benzene, and chloroform) and an effort was given to assess the leishmanicidal activities against Leishmania donovani miltefosine resistant HePC-R (Ld/MIL-30) promastigotes in vitroand the IC50 concentrations were estimated.Results: The study revealed that the semi-purified fractions of A. mexicana, M. koenigii, and C.tamala have effective antileishmanial activities and the 50% inhibitory concentrations (IC50) are 50 μg/ml, 98 μg/ml, and 200 μg/ml, respectively. At these (IC50) concentrations, these plant semi-purified fractions were found to interfere in lipid and protein biosynthesis, alter cell morphology, DNA content, mitochondrial membrane potential, generating ROS, and apoptosis in promastigotes. The semi-purified fractions were also found noticeably non-toxic towards host splenocytes.Conclusion: These results could suggest that A. mexicana, M. koenigii, and C.tamala could carry potential novel compounds for the development of new drugs against Leishmaniasis.
Click on an image to view it in the image viewer
There are no comments for this item.